Home/Filings/4/0001213900-21-056737
4//SEC Filing

Tesi Raymond Joseph 4

Accession 0001213900-21-056737

CIK 0001711754other

Filed

Nov 3, 8:00 PM ET

Accepted

Nov 4, 4:00 PM ET

Size

4.7 KB

Accession

0001213900-21-056737

Insider Transaction Report

Form 4
Period: 2021-11-03
Tesi Raymond Joseph
DirectorPresident & CEO10% Owner
Transactions
  • Sale

    Common Stock

    2021-11-03$20.00/sh3,626$72,5201,490,674 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Documents

1 file

Issuer

Inmune Bio, Inc.

CIK 0001711754

Entity typeother

Related Parties

1
  • filerCIK 0001767280

Filing Metadata

Form type
4
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 4:00 PM ET
Size
4.7 KB